- Report
- October 2024
- 73 Pages
Europe
From €2919EUR$3,250USD£2,500GBP
- Report
- December 2024
- 80 Pages
United States
From €4445EUR$4,950USD£3,807GBP
- Report
- May 2025
- 200 Pages
Middle East
From €2236EUR$2,490USD£1,915GBP
- Report
- February 2025
- 100 Pages
United States
From €2236EUR$2,490USD£1,915GBP
- Report
- April 2025
- 127 Pages
Europe
From €3053EUR$3,400USD£2,615GBP
€3592EUR$4,000USD£3,077GBP
- Report
- August 2024
- 130 Pages
North America
From €3053EUR$3,400USD£2,615GBP
€3592EUR$4,000USD£3,077GBP
- Report
- February 2025
- 116 Pages
North America
From €3098EUR$3,450USD£2,654GBP
- Report
- February 2025
- 123 Pages
Asia Pacific
From €3098EUR$3,450USD£2,654GBP
- Report
- February 2025
- 118 Pages
Middle East, Africa
From €3098EUR$3,450USD£2,654GBP
- Report
- February 2025
- 125 Pages
Europe
From €3098EUR$3,450USD£2,654GBP
- Report
- June 2024
- 140 Pages
Asia Pacific
From €3475EUR$3,869USD£2,976GBP
- Report
- June 2024
- 140 Pages
Europe
From €3475EUR$3,869USD£2,976GBP
- Report
- June 2024
- 140 Pages
Europe
From €3475EUR$3,869USD£2,976GBP
- Report
- March 2022
- 405 Pages
Global
From €4310EUR$4,799USD£3,691GBP
- Report
- January 2024
- 307 Pages
Global
From €5257EUR$6,058USD£4,350GBP
- Report
- December 2023
- 220 Pages
Global
From €4490EUR$5,000USD£3,846GBP
- Report
- December 2022
- 211 Pages
Global
From €5388EUR$6,000USD£4,615GBP
- Report
- March 2022
- 312 Pages
Global
From €6287EUR$7,000USD£5,384GBP
- Report
- August 2023
- 1500 Pages
Global
From €7858EUR$8,750USD£6,730GBP
- Report
- October 2022
- 348 Pages
Singapore, Malaysia, Indonesia Singapore, Malaysia, Indonesia
From €4490EUR$5,000USD£3,846GBP

The biopsy market within the context of In Vitro Diagnostics (IVD) is a segment of the healthcare industry that focuses on the diagnosis of diseases and conditions through the analysis of biological samples. Biopsy tests are used to detect a wide range of conditions, including cancer, infections, and autoimmune diseases. The biopsy market is composed of a variety of products and services, including biopsy needles, biopsy forceps, biopsy punches, and biopsy kits. These products are used to collect tissue samples from patients for further analysis.
The biopsy market is driven by the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the development of advanced technologies. Additionally, the increasing adoption of minimally invasive procedures and the rising demand for cost-effective diagnostic solutions are expected to drive the growth of the biopsy market.
Some of the major companies in the biopsy market include Becton Dickinson, Cook Medical, Olympus Corporation, Stryker Corporation, and Hologic Inc. Show Less Read more